- 专利标题： PHARMACEUTICAL COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM OF A DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY PHASE AND COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE
-
申请号： US17632664申请日： 2020-08-04
-
公开(公告)号： US20220288022A1公开(公告)日： 2022-09-15
- 发明人: Catherine BULCOURT , Alice DENIS , Séverine SIGURANI
- 申请人： SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
- 申请人地址： FR Paris Cedex 07
- 专利权人： SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
- 当前专利权人： SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
- 当前专利权人地址： FR Paris Cedex 07
- 优先权： FRFR1909117 20190809
- 国际申请： PCT/FR2020/051430 WO 20200804
- 主分类号： A61K31/404
- IPC分类号： A61K31/404 ; A61K9/00 ; A61K9/107 ; A61K47/10 ; A61K31/196 ; A61K31/216 ; A61K31/381 ; A61K31/192 ; A61K47/34
摘要：
Topical pharmaceutical composition as a dispersed phase based on a short diol in a continuous fatty phase and including an anti-inflammatory substance, the composition including: a gelled phase including an anti-inflammatory substance and a diol including 3-8 carbon atoms and represented either by formula (Ia): Ra1—(Rb1)(OH)—(OH)(Rc1)(Rd1) (Ia), in which each of the radicals Ra1, Rb1, Rc1 and Rd1 represents, independently of each other, a hydrogen atom or a saturated aliphatic radical including 1-5 carbon atoms, or by formula (Ib): Ra1—C(Rb1)(OH)—[C(Re1)(Rf1)]t—C(OH)(Rc1)(Rd1) (Ib), t=1, 2 or 3, each of the radicals Ra1, Rb1, Rc1 Rd1, Re1 and Rf1 represents, independently of each other, a hydrogen atom or a saturated aliphatic radical including 1-5 carbon atoms. The radicals Ra1or Rb1 and/or the radicals Rc1or Rd1does not represent a hydrogen atom, a fatty phase including an oil and an emulsifying system including a combination of emulsifying surfactants.
信息查询
IPC分类:
